Pharma-Bio Serv, Inc. (PBSV)
OTCMKTS · Delayed Price · Currency is USD
0.5800
+0.0415 (7.71%)
At close: Dec 22, 2025
Pharma-Bio Serv Revenue
Pharma-Bio Serv had revenue of $1.96M in the quarter ending July 31, 2025, a decrease of -18.82%. This brings the company's revenue in the last twelve months to $9.18M, down -14.75% year-over-year. In the fiscal year ending October 31, 2024, Pharma-Bio Serv had annual revenue of $9.51M, down -43.99%.
Revenue (ttm)
9.18M
Revenue Growth
-14.75%
P/S Ratio
1.45
Revenue / Employee
122.46K
Employees
75
Market Cap
13.29M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Oct 31, 2024 | 9.51M | -7.47M | -43.99% |
| Oct 31, 2023 | 16.98M | -2.42M | -12.48% |
| Oct 31, 2022 | 19.40M | -716.45K | -3.56% |
| Oct 31, 2021 | 20.12M | -1.45M | -6.72% |
| Oct 31, 2020 | 21.56M | 2.06M | 10.55% |
| Oct 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Oct 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Oct 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Oct 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Oct 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oncology Network | 1.76B |
| Veradigm | 588.02M |
| Glass House Brands | 196.17M |
| Global Cord Blood | 196.10M |
| Elite Pharmaceuticals | 122.89M |
| Silence Therapeutics | 25.83M |
| OpGen | 9.00M |
| Northwest Biotherapeutics | 937.00K |
Pharma-Bio Serv News
- 3 months ago - Pharma-Bio Serv Announces Results for the Quarter Ended July 31, 2025 - Accesswire
- 6 months ago - Pharma-Bio Serv Announces Results for the Quarter Ended April 30, 2025 - Accesswire
- 10 months ago - Pharma-Bio Serv reports revenue of $2.5 million for quarter ended January 31, 2025 - Seeking Alpha
- 10 months ago - Pharma-Bio Serv Announces Results for the Quarter Ended January 31, 2025 - Accesswire
- 11 months ago - Pharma-Bio Serv reports FY results - Seeking Alpha
- 11 months ago - Pharma-Bio Serv declares $0.075 dividend - Seeking Alpha
- 11 months ago - Pharma-Bio Serv Announces Full Year Results - Accesswire
- 11 months ago - Pharma-Bio Serv Announces Special Dividend - Accesswire